CONTRIBUTORS
Hooman Kamel, MD, MS Guest Editor
Vice Chair for Research, Department of Neurology, Weill Cornell Medicine, New York, New York
Relationship Disclosure: Dr Kamel has received personal compensation in the range of $10,000 to $49,999 for serving as an editor, associate editor, or editorial advisory board member for the Journal of the American Medical Association Neurology, and in the range of $50,000 to $99,999 for serving on an endpoint adjudication committee for Boehringer-Ingelheim.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Kamel reports no disclosure.
Neil A. Busis, MD, FAAN
Associate Chair, Technology and Innovation, Department of Neurology, NYU Langone Health, New York, New York
Relationship Disclosure: Dr Busis has received personal compensation in the range of $0 to $499 for serving as an editor, associate editor, or editorial advisory board member for Neurology Today from the American Academy of Neurology (AAN) and in the range of $500 to $4999 for serving as a speaker for the AAN and as the AAN’s primary advisor to the American Medical Association’s CPT Editorial Panel.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Busis reports no disclosure.
Seemant Chaturvedi, MD, FAAN, FAHA
Stewart J. Greenebaum Endowed Professor of Stroke Neurology, University of Maryland School of Medicine, Baltimore, Maryland
Relationship Disclosure: Dr Chaturvedi has received personal compensation in the range of $500 to $4999 for serving as a consultant for AstraZeneca and on a scientific advisory or data safety monitoring board for the University of Calgary, and in the range of $10,000 to $49,999 for serving as an editor, associate editor, or editorial advisory board member for the American Heart Association and as an expert witness for Ramar & Paradiso (Troy, MI) and Cole, Scott, & Kissane (Palm Beach, FL). The institution of Dr Chaturvedi has received research support from the National Institute of Neurological Disorders and Stroke.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Chaturvedi reports no disclosure.
Luana Ciccarelli, CPC, CRC
Associate Director, Medical Economics and Practice, American Academy of Neurology, Minneapolis, Minnesota
Relationship Disclosure: Ms Ciccarelli reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Ms Ciccarelli reports no disclosure.
Bruce H. Cohen, MD, FAAN
Director, The NeuroDevelopmental Science Center, Akron Children’s Hospital, Akron, Ohio
Relationship Disclosure: Dr Cohen has received personal compensation in the range of $500 to $4999 for serving as a speaker for the American Academy of Neurology (AAN) and as an AAN advisor to the American Medical Association’s CPT Editorial Panel. Dr Cohen has received personal compensation in the range of $0 to $499 for serving as a consultant for CoA Therapeutics/BridgeBio and Neuroene Therapeutics; in the range of $500 to $4999 for serving as a consultant for Abliva AB, Astellas Pharma Inc, Modis/Zogenix, PTC Therapeutics, and Reneo Pharmaceuticals, Inc. The institution of Dr Cohen has received research support from Abliva, BioElectron Technologies/PTC Therapeutics, Astellas Pharma Inc, Reneo Pharmaceuticals, Inc., and Stealth BioTherapeutics, Inc. Dr Cohen has received publishing royalties from a publication relating to health care and has noncompensated relationships as the president of the board of directors of the Child Neurology Society and as a member of the board of directors of the Child Neurology Foundation that are relevant to the American Academy of Neurology interests or activities.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Cohen reports no disclosure.
Christine Fox, MD
Associate Professor of Neurology and Pediatrics, University of California San Francisco, San Francisco, California
Relationship Disclosure: The institution of Dr Fox has received personal compensation in the range of $500 to $4999 for serving as a consultant for Competitive Drug Development International Ltd, research support from the American Heart Association/Bugher Foundation, and from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, and has received publishing royalties from a publication relating to health care.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Fox discusses the use of thrombolysis and thrombectomy for the treatment of stroke in children.
James C. Grotta, MD, FAAN
Director of Stroke Research and Mobile Stroke Unit at the Memorial Hermann Hospital, Texas Medical Center in Houston, Texas
Relationship Disclosure: Dr Grotta has received personal compensation in the range of $5000 to $9999 for serving on a scientific advisory or data safety monitoring board for Haemonetics and Prolong Pharmaceuticals and in the range of $10,000 to $49,999 for serving as a consultant for Frazer Ltd and on a scientific advisory or data safety monitoring board for Acticor Biotech. The institution of Dr Grotta has received research support from Chiesi, CSL Behring, and Genentech. Dr Grotta has received publishing royalties from publications relating to health care.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Grotta reports no disclosure.
Ava L. Liberman, MD
Assistant Professor, Weill Cornell Medicine, New York, New York
Relationship Disclosure: The institution of Dr Liberman has received research support from the National Institutes of Health.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Liberman reports no disclosure.
James F. Meschia, MD, FAAN
Professor of Neurology; Frances Bartlett Kinne Professor, Mayo Clinic, Jacksonville, Florida
Relationship Disclosure: The institution of Dr Meschia has received research support from the National Institute of Neurological Disorders and Stroke.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Meschia reports no disclosure.
Thanh Ngoc Nguyen, MD
Director of Interventional Neurology and Neuroradiology, Boston Medical Center; Professor of Neurology, Neurosurgery, and Radiology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts
Relationship Disclosure: Dr Nguyen has received personal compensation in the range of $0 to $499 for serving on a scientific advisory or data safety monitoring board for the National Institutes of Health, and in the range of $500 to $4999 for serving on a scientific advisory or data safety monitoring board for Avania, Idorsia Pharmaceuticals, and Vesalio, and as an editor, associate editor, or editorial advisory board member for the American Heart Association. The institution of Dr Nguyen has received research support from Medtronic and the Society of Vascular and Interventional Neurology.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Nguyen reports no disclosure.
Michael W. O’Dell, MD
Professor Emeritus of Rehabilitation Medicine, Department of Rehabilitation Medicine, Weill Cornell Medicine, New York, New York
Relationship Disclosure: Dr O’Dell has received personal compensation in the range of $0 to $499 for serving as an officer or member of the board of directors for Franklin College of Indiana, and in the range of $500 to $4999 for serving on a scientific advisory or data safety monitoring board for Merz Pharmaceuticals, LLC.
Unlabeled Use of Products/Investigational Use Disclosure: Dr O’Dell discusses several clinical trials involving the use of investigational drugs, none of which are US Food and Drug Administration (FDA) approved for use in people with stroke.
Setareh Salehi Omran, MD
Assistant Professor of Neurology, University of Colorado School of Medicine, Aurora, Colorado
Relationship Disclosure: Dr Salehi Omran reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Salehi Omran reports no disclosure.
Anjail Sharrief, MD, MPH, FAHA
Associate Professor of Neurology, McGovern Medical School, University of Texas Health Sciences Center, Houston, Texas
Relationship Disclosure: The institution of Dr Sharrief has received research support from the National Institutes of Health and from the University of Houston. Dr Sharrief has a non-compensated relationship as a consultant with Abbot Laboratories that is relevant to the American Academy of Neurology interests or activities.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Sharrief reports no disclosure.
Sunil Sheth, MD
Associate Professor, Department of Neurology; Director, Division of Vascular and Interventional Neurology, University of Texas Health Sciences Center, Houston, Texas
Relationship Disclosure: Dr Sheth has received personal compensation in the range of $500 to $4999 for serving as a consultant for CERENOVUS and Imperative Care, and in the range of $100,000 to $499,999 for serving as a consultant for Penumbra Inc.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Sheth reports no disclosure.
Raissa Villanueva MD, MPH, FAAN
Division Chief, General Neurology Division, University of Rochester Medical Center, Rochester, New York
Relationship Disclosure: Dr Villanueva has received personal compensation in the range of $500 to $4999 for serving as a speaker for the American Academy of Neurology (AAN) and as the AAN’s alternate advisor to the American Medical Association’s CPT Editorial Panel. Dr Villanueva has a noncompensated relationship as a practice management committee member with the American Headache Society that is relevant to the American Academy of Neurology interests or activities.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Villanueva reports no disclosure.
Shadi Yaghi, MD
Associate Professor of Neurology, Brown University, Providence, Rhode Island
Relationship Disclosure: Dr Yaghi reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Yaghi reports no disclosure.
Self-Assessment and CME Test Writers
Allyson R. Zazulia, MD
Professor of Neurology and Radiology; Associate Dean for Continuing Medical Education, Washington University, St. Louis, Missouri
Relationship Disclosure: Dr Zazulia reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Zazulia reports no disclosure.
Douglas J. Gelb, MD, PhD, FAAN
Professor of Neurology, University of Michigan, Ann Arbor, Michigan
Relationship Disclosure: Dr Gelb has received personal compensation in the range of $500 to $4999 for serving as a multiple-choice question writer for Continuum with the American Academy of Neurology. Dr Gelb has received publishing royalties from a publication relating to health care.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Gelb reports no disclosure.
